메뉴 건너뛰기




Volumn 36, Issue 5, 2015, Pages 399-406

Erratum: Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey (Allergy and Asthma Proceedings (2015) 36 (399-406) DOI: 10.2500/aap.2015.36.3892);Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey

(38)  Longhurst, Hilary J a   Aberer, Werner b   Bouillet, Laurence c   Caballero, Teresa d   Fabien, Vincent e   Zanichelli, Andrea f   Maurer, Marcus g   Bygum, A h   Delaunay, C Blanchard c   Boccon Gibod, I c   Fain, O c   Gompel, A c   Guez, S c   Jeandel, P Y c   Kanny, G c   Launay, D c   Maillard, H c   Martin, L c   Masseau, A c   Ollivier, Y c   more..

h NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; ICATIBANT; OXANDROLONE; STANOZOLOL; TRANEXAMIC ACID; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST;

EID: 84942568799     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2015.36.1014     Document Type: Erratum
Times cited : (20)

References (21)
  • 1
    • 84856654320 scopus 로고    scopus 로고
    • Hereditary angio-oedema
    • Longhurst H, and Cicardi M. Hereditary angio-oedema. Lancet 379:474-481, 2012.
    • (2012) Lancet , vol.379 , pp. 474-481
    • Longhurst, H.1    Cicardi, M.2
  • 2
    • 84877113122 scopus 로고    scopus 로고
    • Hereditary angioedema: Epidemiology, management, and role of icatibant
    • Ghazi A, and Grant JA. Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics 7:103-113, 2013.
    • (2013) Biologics , vol.7 , pp. 103-113
    • Ghazi, A.1    Grant, J.A.2
  • 3
    • 4444225379 scopus 로고    scopus 로고
    • Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
    • Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004.
    • (2004) J Allergy Clin Immunol , vol.114 , pp. S51-S131
    • Agostoni, A.1    Aygoren-Pursun, E.2    Binkley, K.E.3
  • 4
    • 84858966009 scopus 로고    scopus 로고
    • Hereditary and acquired complement component 1 esterase inhibitor deficiency: A review for the hematologist
    • Cicardi M, and Johnston DT. Hereditary and acquired complement component 1 esterase inhibitor deficiency: A review for the hematologist. Acta Haematol 127:208-220, 2012.
    • (2012) Acta Haematol , vol.127 , pp. 208-220
    • Cicardi, M.1    Johnston, D.T.2
  • 5
    • 60949104520 scopus 로고    scopus 로고
    • C1-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress
    • Cugno M, Zanichelli A, Foieni F, et al. C1-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress. Trends Mol Med 15:69-78, 2009.
    • (2009) Trends Mol Med , vol.15 , pp. 69-78
    • Cugno, M.1    Zanichelli, A.2    Foieni, F.3
  • 6
    • 77954311687 scopus 로고    scopus 로고
    • The plasma bradykinin-forming pathways and its interrelationships with complement
    • Kaplan AP, and Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 47:2161-2169, 2010.
    • (2010) Mol Immunol , vol.47 , pp. 2161-2169
    • Kaplan, A.P.1    Ghebrehiwet, B.2
  • 7
    • 84987657462 scopus 로고    scopus 로고
    • The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe
    • Caballero T, Aygoren-Pursun E, Bygum A, et al. The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35:47-53, 2014.
    • (2014) Allergy Asthma Proc , vol.35 , pp. 47-53
    • Caballero, T.1    Aygoren-Pursun, E.2    Bygum, A.3
  • 8
    • 79956316229 scopus 로고    scopus 로고
    • Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007
    • Zilberberg MD, Nathanson BH, Jacobsen T, and Tillotson G. Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004-2007. Allergy Asthma Proc 32:248-254, 2011.
    • (2011) Allergy Asthma Proc , vol.32 , pp. 248-254
    • Zilberberg, M.D.1    Nathanson, B.H.2    Jacobsen, T.3    Tillotson, G.4
  • 9
    • 84865676871 scopus 로고    scopus 로고
    • Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency
    • Bork K, Hardt J, and Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130:692-697, 2012.
    • (2012) J Allergy Clin Immunol , vol.130 , pp. 692-697
    • Bork, K.1    Hardt, J.2    Witzke, G.3
  • 10
    • 84873508381 scopus 로고    scopus 로고
    • Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment
    • Maurer M, Aberer W, Bouillet L, et al. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One 8:e53773, 2013.
    • (2013) PLoS One , vol.8 , pp. e53773
    • Maurer, M.1    Aberer, W.2    Bouillet, L.3
  • 11
    • 77955295556 scopus 로고    scopus 로고
    • Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
    • Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363:532-541, 2010.
    • (2010) N Engl J Med , vol.363 , pp. 532-541
    • Cicardi, M.1    Banerji, A.2    Bracho, F.3
  • 12
    • 82955233701 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial
    • Lumry WR, Li HH, Levy RJ, et al. Randomized placebo-controlled trial of the bradykinin B(2) receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol 107:529-537, 2011.
    • (2011) Ann Allergy Asthma Immunol , vol.107 , pp. 529-537
    • Lumry, W.R.1    Li, H.H.2    Levy, R.J.3
  • 13
    • 84907044494 scopus 로고    scopus 로고
    • Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting
    • Maurer M, Longhurst HJ, Fabien V, et al. Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting. Allergy Asthma Proc 35:377-381, 2014.
    • (2014) Allergy Asthma Proc , vol.35 , pp. 377-381
    • Maurer, M.1    Longhurst, H.J.2    Fabien, V.3
  • 14
    • 84865615187 scopus 로고    scopus 로고
    • Hereditary angioedema treatment options: The availability of new therapies
    • Aberer W. Hereditary angioedema treatment options: The availability of new therapies. Ann Med 44:523-529, 2012.
    • (2012) Ann Med , vol.44 , pp. 523-529
    • Aberer, W.1
  • 15
    • 84894235031 scopus 로고    scopus 로고
    • Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
    • Aberer W, Maurer M, Reshef A, et al. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy 69:305-314, 2014.
    • (2014) Allergy , vol.69 , pp. 305-314
    • Aberer, W.1    Maurer, M.2    Reshef, A.3
  • 17
    • 79952051526 scopus 로고    scopus 로고
    • Management of acute attacks of hereditary angioedema: Potential role of icatibant
    • Longhurst HJ. Management of acute attacks of hereditary angioedema: Potential role of icatibant. Vasc Health Risk Manag 6:795-802, 2010.
    • (2010) Vasc Health Risk Manag , vol.6 , pp. 795-802
    • Longhurst, H.J.1
  • 18
    • 79953187961 scopus 로고    scopus 로고
    • Diagnosis and management of hereditary angioedema
    • Johnston DT. Diagnosis and management of hereditary angioedema. J Am Osteopath Assoc 111:28-36, 2011.
    • (2011) J Am Osteopath Assoc , vol.111 , pp. 28-36
    • Johnston, D.T.1
  • 19
    • 84855779242 scopus 로고    scopus 로고
    • Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group
    • Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group. Allergy 67:147-157, 2012.
    • (2012) Allergy , vol.67 , pp. 147-157
    • Cicardi, M.1    Bork, K.2    Caballero, T.3
  • 20
    • 84924959789 scopus 로고    scopus 로고
    • Pharmacokinetics of single and repeat doses of icatibant
    • 10.1002/cpdd.138
    • Leach JK, Spencer K, Mascelli M, et al. Pharmacokinetics of single and repeat doses of icatibant. Clin Pharm Drug Dev 10.1002/cpdd.138, 2014.
    • (2014) Clin Pharm Drug Dev
    • Leach, J.K.1    Spencer, K.2    Mascelli, M.3
  • 21
    • 84942567681 scopus 로고    scopus 로고
    • Icatibant for the treatment of repeated attacks of hereditary angioedema: FAST-3 trial openlabel extension study phase
    • Lumry W, Levy R, Li H, et al. Icatibant for the treatment of repeated attacks of hereditary angioedema: FAST-3 trial openlabel extension study phase. Allergy 68(suppl. 97):254-255, 2013.
    • (2013) Allergy , vol.68 , pp. 254-255
    • Lumry, W.1    Levy, R.2    Li, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.